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ABSTRACT 
 
This study determines if differences in per capita health care cost and health outcomes among 
OECD countries can be explained by the extent to which national health expenditures is publicly 
financed. The study controls, whenever multicollinearity issues can be avoided, for indicators of 
the quality of the health care system, health inputs and health risk factors. Using multiple 
regression analysis, the study finds that the quality of the health care system, not the extent of 
public subsidy, is the more statistically significant determinant of the cross-country variance in 
health outcomes.   
 
 
INTRODUCTION 
 
he political debate about whether the U.S. should move towards universal coverage is reemerging as 
a key issue in the upcoming presidential elections. Of the 30 members of the Organization for 
Economic Cooperation and Development (OECD) only the U.S., Turkey and Mexico do not have 
publicly funded health systems that cover all, if not the majority, of its residents. For all 30 countries,  94% of the 
population, on average, are covered by public health insurance (OECD Health Data 2006). Among the 27 countries 
that have universal coverage, funding of health care services are either from general tax revenues or from some kind 
of a separate social security fund.  Medical services are, in rare cases (e.g. Great Britain and Spain), administered 
and provided by the government. In many cases, health care providers are private entities reimbursed by a single 
public payer (e.g. Canada, Denmark, Norway, Italy and Sweden) or by multi-payer sickness funds that pay annually 
negotiated, uniform rates for physicians and hospitals (e.g. France and Germany). Many countries also have private 
health insurance companies that sell coverage to those who can afford it and want to supplement the basic public 
insurance coverage.  
 
The average composition of health care financing in OECD countries as of 2004 is public financing (73%), 
out-of-pocket payments for copays, deductibles or for services not covered by public insurance (19%), private health 
insurance and other private financing (8%). In the U.S., the corresponding percentages are 45%, 15%, and 40% 
(OECD Health Data 2006).  However, the public share of total health expenditure in the U.S. has grown faster than 
the average for all OECD countries since the 1980s. This faster growth is due to increasing support for universal 
coverage at the state level where several legislations have been passed to relax eligibility rules for Medicaid to cover 
adults with incomes up to 130% of the poverty threshold, and to expand coverage to children through the Children’s 
Health Insurance Program (CHIP). More recently, Massachusetts passed a legislation making health insurance 
mandatory like car insurance, and providing low-cost health insurance from tax revenues to the not-so-poor but 
uninsured.     At the Federal level, prescription drug coverage for the low-income elderly was added to the Medicare 
program in 2006. 
 
REVIEW OF RELATED STUDIES 
 
One component of the health care financing debate in the U.S. centers on what medical services would be 
cost-effectively paid for by public funds. Many would agree that public funds should pay for health care services of 
the poor because health care is a public good like education and would be underprovided by the private sector.  
Positive externalities that have been cited range from the more obvious fact that the spread of communicable 
diseases would be curbed if free immunization were available to all, to the increase in productivity arising from a 
T 
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healthy work force and global competitiveness arising from reduced absenteeism (Blanchette and Tolley, 1997). 
Musgrove (1999) advocated public financing of health services for which demand is inadequate (either because it 
involves rare diseases or there are substantial externalities involved), cost-effective interventions for the poor, health 
care services that are catastrophically costly even for the nonpoor, and when contributory insurance will not work. In 
a discussion paper released by The Hamilton Project, Jeanne Lambrew (2007) proposed universal health care 
coverage that is limited to preventive services and wellness promotion, with no required cost-sharing to increase 
utilization. The goal is to contain health care cost over the long-term by (a) promoting healthy lifestyles and (b) 
early detection and treatment of five chronic diseases (stroke, cancer, diabetes, cardiovascular and chronic 
obstructive pulmonary diseases) which account for two-thirds of all deaths in the U.S. Lambrew envisions that no 
new taxes need to be raised as funds can be carved out of existing public health care programs. 
 
Supporters of universal health coverage argue that a single payer will be able to negotiate lower prices with 
health care providers, and administrative costs will be reduced. The high administrative costs of tracking eligibility, 
covered services, and reimbursement rates of multiple public and private health insurance organizations account for 
about 5% of national health expenditure in the U.S., at least twice the share in countries with a single payer system. 
Lu and Hsiao (2003) found empirical evidence that Taiwan’s adoption of universal health coverage has resulted in 
the reduction of the country’s health care costs after controlling for demographic and economic changes over time. 
Other proponents of universal health coverage argue that countries where most, if not all, people have health 
insurance have longer life expectancies and lower infant mortality rates. Hogberg (2006) found this argument to be 
flawed because life expectancy and infant mortality do not depend on access to the health care system only, but also 
on genetics, diet, lifestyle risks, income, literacy, as well as incidence of accidents. One may add the effects of the 
incidence of crime and other environmental risks. Empirical studies using international data that support the 
multiplicity of health determinants include Ricci and Zachariadis (2006) and Furukawa (2005).  
 
Holstein and Foreman (2007) provides a detailed review of empirical studies using data within the U.S. 
only. Using data for the 50 states of the U.S. from 1999-2002, they found that after controlling for socioeconomic 
factors, lifestyle and environmental risks, the interstate variances in both life expectancy and infant mortality rates 
were significantly associated with the generosity (measured by average spending per beneficiary) of the Medicaid 
health insurance program for the poor and the disabled.  In an earlier study using international data, Holstein (2004) 
found that fairness of health care financing was a significant determinant of longer healthy life expectancy and lower 
infant mortality. She also found that the responsiveness of the health system was significantly associated with longer 
healthy life expectancy. Although that study controlled for literacy and health risks, however, it did not control for 
the role of the extent to which health expenditures are publicly funded. Thus, this study addresses this deficiency 
while controlling for the quality of the health care system, health inputs, and health risk factors.  
 
DATA AND METHODOLOGY 
 
In 2002, the OECD published a Health Systems Report based on a time-series database it developed for its 
30 member countries (OECD Health Data 2002). Measures of performance or quality of health systems in 191 
countries were developed by the World Health Organization (WHO) in 1999.  A composite index of overall 
efficiency was derived from the weighted average of indices gauging the health system’s responsiveness, the 
average healthy (or disability-free) life expectancy, and fairness in the distribution of financial burden (Arnesen and 
Nord, l999; Wagstaff, et al, l999). The U.S. ranked 37
th
, in a list in which France, Italy, and three small countries 
(San Marino, Andorra and Malta) were the top five. The index of responsiveness, in particular, was based on an 
international survey asking respondents to rate the promptness of intervention, choice of provider, and respect for 
patient’s privacy, among others. The U.S. ranked first in responsiveness, followed by Switzerland, Luxembourg, 
Denmark and Germany. As to healthy life expectancy, the estimated 70.1 years of healthy life expectancy of an 
American male puts the U.S. in the 24
th
 place, in a list topped by Japan, Australia, France, Sweden and Spain.  
Fairness of the health system was gauged based on the extent to which other members of society through tax-
financed public subsidies share the health care cost of the elderly, the poor and the disabled. Here, the U.S. ranked 
54 -55 (a tie with Fiji) in a list headed by Columbia, Luxembourg, Belgium, Denmark and Germany (World Health 
Report 2000).  
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Table 1 compares the U.S. with a peer group of 22 other OECD countries with per capita heath care costs 
(PCHC) above $1,000 adjusted for purchasing power parity (PPP).  The U.S. ranks first in terms of per capita health 
care cost and the responsiveness of the health care system. However, it lags behind its peer group in terms of health 
outcomes (combined male and female average life expectancy, healthy male life expectancy, and infant mortality 
rate, share of public financing, fairness of health care financing, availability of physicians, and the prevalence of 
smoking). 
 
 
Table 1 
Descriptive Health-related Statistics for OECD Countries, l999 
                                                                                         U.S.  Only          Average for 22 OECD Countries  
                                                                                                                            with PCHC > $1,000                                                                                                                                                                                                                        
                                                                                     Rank             Value                                         
Per Capita Health Cost (PCHC in PPP dollars)             1                 4373                             2051             
Public Financing to  Health Expenditure (%)               29                 44.3                             74.5                  
Prevalence of Smoking (%)                                          30                 19.1                              27.9 
Doctors (per 1000 people)                                            19                   2.8                                3.1                 
Infant Mortality Rate (Deaths per 1000 live births)      25                  7.1                               4.6 
Average (M, F ) Life Expectancy (years)                     20                76.6                               78.3             
Healthy Life Expectancy (years)                                   19                70.1                              71.6    
Health System Quality Index:  
   Responsiveness                                                           1                    8.1                                6.8                                                  
   Fairness                                                                      24                   0.95                              0.97 
Sources:  OECD Health Data 2002: A Comparative Analysis of 30 Countries: 2002 ed. 
                 World Health Report 2000 (Geneva: World Health Organization, 2000). 
 
 
The WHO’s indices of the health care system’s  responsiveness and fairness of financing   for 1999 are 
matched with same year OECD data on per capita health expenditure, healthy life expectancy, average of male and 
female life expectancies, public share of health expenditure, the availability of physicians, and a health risk factor - 
prevalence of smoking. Other possible control variables (health care inputs, share of medical durables to total 
expenditures, educational attainment, out-of-pocket payments) were excluded because their inclusion in a multiple 
regression analysis would prevent me from isolating the separate effect of the public share of health expenditure (i.e. 
their correlation coefficients with this variable of interest exceeded 0.10).  The regression equations estimated are: 
 
lnPCHC = b10   +  b11 PUBHX  +  b12 RESP  +  b13 RISK  + e1  Eq. 1 
HLXP =  b20   +  b21 PUBHX  +  b22 RESP  +  b23 RISK   +  e2.  Eq. 2 
LXP =  b30   + b31 PUBHX  +  b32 RESP  +  b33 RISK   +  e3.   Eq. 3 
IMR =  b40   + b41 PUBHX  +   b42 RESP  +  b43 DOCS  +  e4.    Eq. 4 
IMR = b50   + b51 PUBHX  +  b52 FAIR  +  b53 DOCS  +  e5.     Eq. 5 
 
where PCHX is the per capita health care expenditure, PUBHX is the public share of health care expenditure, HLXP 
is healthy (disability-free) male life expectancy, LXP is the average of male and female life expectancies not 
adjusted for disabilities, IMR is infant mortality rate, RESP is the responsiveness index of the health care system, 
RISK is the prevalence of smoking (a health risk proxy), FAIR is the fairness index of the health care system, and 
DOCS is the availability of physicians. 
 
A semi-logarithmic functional form is used in Eq.1 to ensure non-negative predicted values for PCHC. To 
determine the role of the public share of health expenditure in explaining the cross-country variance in infant 
mortality rates (IMR), countries with very high IMR like Mexico and Turkey are excluded. In addition, the U.S. is 
excluded because the way live births are defined in this country makes the calculated IMR significantly different 
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from other OECD countries (Hogberg 2006). With a sample size (n) of 27 countries, it was possible to include the 
availability of physicians as a control variable, and also to alternately use health system responsiveness and fairness 
of health care financing as indicators of the quality of the health care system. 
 
Table 2 provides a correlation matrix for the variables used in the analysis. The null hypotheses to be tested 
can be summarized as: 
 
b11 = b12 = b13 = b21  = b22  = b23 = b31 = b32 = b33 = b41 = b42 = b43 = b51 = b52 = b53 = 0. 
 
 
Table 2 
Correlation Matrix 
 PUBHX PCHX HLXP LXP IMR 
Responsiveness (n=30) -0.05 0.94 0.68 0.77 -0.72 
Fairness (n=27) 0.27 0.74 0.70 0.78 -0.42 
Prevalence of Smoking (n=30) -0.09 -0.30 -0.26 -0.07 0.13 
Availability of Physicians (n=27) 0.17 0.21 0.24 0.17 -0.44 
 
 
Table 3 
Determinants of Health Care Cost 
 Explanatory/Policy Variables                                            Std. Coefficients                                                         t-statistics 
 Public Share of Health Expenditure (%)                                      0.01                                                                         1.63 
 Responsivess Index                                0.82***                                                                   13.02 
 Prevalence of Smoking                                                              - 0.00                                                                        -0.69 
             Constant                                                                         1.75*** 
             R2                 0.88 
             Adj. R2         0.87 
             F                  65.67                                     
 
 
Table 4 
Determinants of Health Outcomes 
 Explanatory/Policy Variables                        HLXP                            LXP                             IMR                            IMR 
 Public Share of Health Exp. (%)                       0.04                              0.01                             -0.02                           -0.01 
 Responsivess Index                   3.05***                       2.80***                       -1.91***  
 Fairness Index                                                     -59.95*** 
 Prevalence of Smoking                                    -0.01                              -0.06    
 Availability of Physicians                                                                                                          -0.06                           -0.08 
             Constant                                             47.54***                         59.91***                     19.05***                   64.19***         
             R2                                                        0.50                                0.55                             0.53                             0.66 
             Adj. R2                                                0.44                                0.50                             0.47                             0.61 
             F                                                          8.63                              10.78                            8.64                            14.72 
 
 
ANALYSIS OF FINDINGS 
 
The regression coefficients of equation 1 are summarized in Table 3 while the regression coefficients of 
equations 2 to 5 are summarized in Table 4. There exists a positive but weak statistical association between the 
public share of health expenditure and per capita health care cost.  This would imply that increased public financing 
of health care cost does not necessarily lead to lower average health care cost. What seems to be a more important 
determinant is the responsiveness of the health care system. The more responsive the country’s health care system is, 
the higher is its per capita health care cost.  
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The responsiveness of the health care system is also found to be a statistically significant positive 
determinant of both measures of life expectancy (healthy life expectancy and average life expectancy). Likewise, the 
study finds that the more responsive the health care system is and the more that health care financing is shifted to the 
nonpoor and healthy, the lower the infant mortality rate (see Table 4). The public share of health expenditure, the 
proxies for health risk (prevalence of smoking) and health care input (availability of physicians) are not significant 
determinants of the chosen measures of health outcomes. 
 
CONCLUSION AND POLICY IMPLICATIONS 
         
Limited data for OECD member countries suggest that increased public financing of health care 
expenditures, by itself, may not lead to cost containment or better health outcomes. While increased public financing 
of health care can be supported on grounds of economic efficiency and equity, it is more important that policy 
makers focus on improving the responsiveness of the health care system and making sure that the burden of tax 
revenues is shifted from the poor and the sick to the nonpoor and healthy.   
 
SUGGESTIONS FOR FUTURE RESEARCH 
         
The sample of 30 OECD member countries analysed in this study can be increased to the 191 member 
countries of the World Health Organization. It is important, in my opinion, that the sample be split between high and 
low national income countries, or to control for national income, and to address multicollinearity problems when 
choosing explanatory variables. 
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